Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review.

Stamer WD, Chiu T, Lu DW, Wang TH, Rojanapongpun P, Ruangvaravate N, Jo YH, Moster MR, Fingeret M, Cothran NL, Steen J, Gaddie IB, Uçakhan-Gündüz Ö, Shamseldin Shalaby W, Hutnik CML

Open source

DOI: 10.3389/fopht.2025.1554777
Published: 2025
Container: Frontiers in ophthalmology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fopht.2025.1554777,
  title = {Real-world impact of latanoprostene bunod ophthalmic solution 0.024\% in glaucoma therapy: a narrative review.},
  author = {Stamer WD and Chiu T and Lu DW and Wang TH and Rojanapongpun P and Ruangvaravate N and Jo YH and Moster MR and Fingeret M and Cothran NL and Steen J and Gaddie IB and Uçakhan-Gündüz Ö and Shamseldin Shalaby W and Hutnik CML},
  year = {2025},
  journal = {Frontiers in ophthalmology},
  doi = {10.3389/fopht.2025.1554777},
  url = {https://doi.org/10.3389/fopht.2025.1554777}
}

RIS

TY  - JOUR
TI  - Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review.
AU  - Stamer WD
AU  - Chiu T
AU  - Lu DW
AU  - Wang TH
AU  - Rojanapongpun P
AU  - Ruangvaravate N
AU  - Jo YH
AU  - Moster MR
AU  - Fingeret M
AU  - Cothran NL
AU  - Steen J
AU  - Gaddie IB
AU  - Uçakhan-Gündüz Ö
AU  - Shamseldin Shalaby W
AU  - Hutnik CML
PY  - 2025
JO  - Frontiers in ophthalmology
DO  - 10.3389/fopht.2025.1554777
UR  - https://doi.org/10.3389/fopht.2025.1554777
ER  -

APA

WD, S., T, C., DW, L., TH, W., P, R., N, R., YH, J., MR, M., M, F., NL, C., J, S., IB, G., Ö, U., W, S. S., & CML, H. (2025). Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review.. Frontiers in ophthalmology. https://doi.org/10.3389/fopht.2025.1554777

Source records

pubmed · retrieved 2026-09-26T05:43:59.999Z